Dr. Rebecca Laborde, Postdoctoral Research Fellow at Mayo Clinic in Rochester, MN, shares the results of a study appearing in the March 2012 issue...
» More
Dr. Rebecca Laborde, Postdoctoral Research Fellow at Mayo Clinic in Rochester, MN, shares the results of a study appearing in the March 2012 issue of Mayo Clinic Proceedings, that supports the application of mRNA-seq technology as a way to more accurately stratify patients based on individual tumor biology to improve the understanding of tumor prognosis and treatment responses which would improve individualized patient care strategies. Available at:
Rebecca R. Laborde, Vivian W. Wang, Todd M. Smith, N. Eric Olson, Steven M. Olsen, Joaquin J. Garcia, Kerry D. Olsen, Eric J. Moore, Jan L. Kasperbauer, Nicole M. Tombers, David I. Smith
